Immunoglobulin Products has 4 known drug interactions based on U.S. FDA drug labeling data. Notable interactions include combinations with Efgartigimod Alfa, Efgartigimod Alfa And Hyaluronidase (Human Recombinant), Nipocalimab. Patients taking Immunoglobulin Products should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 4
- Moderate
- 4
Moderate (4)
- Immunoglobulin Products + Efgartigimod Alfa— Concomitant use may lower systemic exposures and reduce effectiveness of immunoglobulin products. Closely monitor for re…
- Immunoglobulin Products + Efgartigimod Alfa And Hyaluronidase (Human Recombinant)— Concomitant use may lower systemic exposures and reduce effectiveness of immunoglobulin products. Closely monitor for re…
- Immunoglobulin Products + Nipocalimab— Concomitant use may lower systemic exposures and reduce effectiveness of immunoglobulin products. Closely monitor for re…
- Immunoglobulin Products + Rozanolixizumab— Concomitant use may lower systemic exposures and reduce effectiveness of immunoglobulin products. Closely monitor for re…